This site requires JavaScript to render the code.

Need to know how to enable JavaScript? Go here.

Prof. dr. Chris Meijer, MD Chief Executive Officer

Prof. dr. Chris Meijer, MD, emeritus professor in Pathology, co-founder, innovator and CEO of Self-screen B.V.. He is a renowned person in the field, and holds a long track record in clinical cervical cancer research. Chris Meijer was Head and Director of the Department of Pathology at the VU University medical center, Amsterdam (1983-2008) and Director of the Oncology Research Institute at VU University (1992-2002). He is (co)author of over 950 international (peer reviewed) papers in his area of expertise and has received several international awards for his outstanding research.

Prof. Dr. Peter Snijders, PhD Chief Scientific Officer In memoriam

Prof. Dr. Peter Snijders, PhD, professor in Molecular Pathology, and co-founder and CSO of Self-screen B.V.. He holds a long-lasting track record in oncology with special focus on HPV-induced cancers and in particular early detection of the disease. He was involved in the development of the clinically validated HPV GP5+/6+ consensus PCR, which is amongst the most widely used consensus HPV PCR method in epidemiology and screening studies. He is (co)author of over 360 international (peer reviewed) papers in his area of expertise, and is inventor of several patents.

Dr. Daniëlle Heideman, PhD. Senior Scientific Officer

Dr. Daniëlle Heideman, PhD., Associate Professor in Molecular Pathology, licensed Clinical Scientist in Molecular Pathology, co-founder and Senior Scientific Officer (SCO) of Self-screen B.V.. She gained her MSc degree in Biomedical Sciences summa cum laude in 1998, and holds a PhD degree in Molecular Oncology from VU University Amsterdam, the Netherlands. In 2007 she became staff member of the department of pathology, and in 2012 she was appointed Associate Professor at the same department.

Dr. Renske Steenbergen, PhD. Senior Scientific Officer

Dr. Renske Steenbergen, PhD., Associate Professor in Molecular Pathology, and co-founder and Senior Scientific Officer (SCO) of Self-screen B.V.. She received her MSc degree in Biomedical Sciences at the University of Leiden, The Netherlands in 1991. In 1992 she worked at the University of California San Diego. In 1993 she started her PhD research at the VU University in Amsterdam and received her PhD degree summa cum laude in 1997. In 2009 she was appointed Associate Professor at the same department.

Wim Ket Chief Financial Officer

Wim Ket, holds a master degree in Law from University of Amsterdam. He has over 15 years of experience in business and corporate law within several international operating companies. He is responsible for financial, HR, legal and entrepreneurial management.

Cedric van der Meulen Business Development Manager

Cedric van der Meulen, obtained his MBA from the Erasmus University Rotterdam and his MSc at the University of Amsterdam. He gained experience as a manager of the VUmc where he was responsible for more than 1.000 FTE. He was involved in several life science startup companies. His main focus is translating market needs into Self-screen’s diagnostic products.